M02.87
Other reactive arthropathies, ankle and foot
Clinical Classification Guidelines
Inclusion Terms
- Other reactive arthropathies, tarsus, metatarsus and phalanges
Medical Intelligence & Overview
Other reactive arthropathies, classified under ICD-10 code M02.87, refer to a group of joint disorders that develop as a reaction to infections or other immune responses, affecting primarily the joints of the ankle, foot, tarsus, metatarsus, and phalanges. These conditions are characterized by inflammation and pain in the affected joints, often occurring after an illness. They are distinct from primary joint diseases because they are triggered by external factors, such as infections or immune reactions, rather than by primary joint degeneration or trauma.
Causes & Symptoms
Clinical Causes: Post-infectious immune response following bacterial, viral, or parasitic infections Infections localized in distant sites, leading to immune-mediated joint inflammation Reactions to certain medications or vaccines Underlying autoimmune disorders that incite joint inflammation Environmental factors that may trigger immune responses in genetically predisposed individuals
Key Symptoms: Pain localized in the ankle, foot, tarsus, metatarsus, or phalanges Swelling and warmth in the affected joints Reduced joint mobility or stiffness, especially after periods of rest Tenderness upon palpation of the involved joints Possible redness of the skin over the joints Persistent or intermittent joint discomfort that may worsen with activity Systemic symptoms such as fatigue or mild fever in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis of other reactive arthropathies involves a comprehensive clinical assessment, including a detailed medical history and physical examination. Diagnostic approaches may include: - Laboratory blood tests to assess inflammatory markers (such as ESR and CRP) - Tests for infectious agents, depending on suspected triggers - Imaging studies like X-rays to evaluate joint swelling and rule out other joint disorders - Synovial fluid analysis if joint effusion is present It is important to distinguish reactive arthropathies from other joint conditions, such as rheumatoid arthritis or gout, for appropriate management.
Treatment Protocols: Treatment strategies for reactive arthropathies aim to reduce inflammation and manage symptoms. Common approaches include: - Nonsteroidal anti-inflammatory drugs (NSAIDs) to alleviate pain and reduce inflammation - Rest and joint immobilization during acute phases - Physical therapy to maintain joint function and flexibility - Corticosteroid injections in cases of severe inflammation - Antibiotics or antivirals if an ongoing infection is identified as a trigger - Monitoring and treating the underlying infection or immune response - Patient education on joint protection and activity modification In most cases, the condition improves with appropriate management, but prolonged or recurrent episodes may require further evaluation and specialized care.
Clinical Advice & FAQs
Billing Guidance
Is M02.87 a billable ICD-10 code?
Yes, M02.87 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M02.87?
Clinical documentation must specify the nature of Other reactive arthropathies, ankle and foot and any associated comorbidities for accurate reporting.
Cite this Clinical Reference